Universitätsklinikum Schleswig-Holstein (UKSH)


Hospital

Location:
Lübeck / Kiel, Germany


Publications in cooperation with FAU scientists


Go to first page Go to previous page 1 of 11 Go to next page Go to last page
Moosig, F., Schmalzing, M., Aries, P.M., Henes, J., Lamprecht, P., Rech, J., & Witte, T. (2019). Actual Treatment Options for Giant Cell Arteritis. Deutsche Medizinische Wochenschrift, 144(9), 595-600. https://dx.doi.org/10.1055/a-0832-3563
Heinzerling, L., Ascierto, P.A., Dummer, R., Gogas, H., Grob, J.-J., Lebbe, C.,... Hauschild, A. (2019). Adverse events 2.0-Let us get SERIOs New reporting for adverse event outcomes needed in the era of immunooncology. European journal of cancer, 112, 29-31. https://dx.doi.org/10.1016/j.ejca.2019.01.015
Kolios, A.G.A., Hueber, A., Michetti, P., Mrowietz, U., Mustak-Blagusz, M., Sator, P.-G.,... Schiefke, I. (2019). ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study. Journal of the European Academy of Dermatology and Venereology, 33(1), 234-241. https://dx.doi.org/10.1111/jdv.15179
Reiff, T., Eckstein, H.H., Mansmann, U., Jansen, O., Fraedrich, G., Mudra, H.,... Ringleb, P.A. (2019). Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: One-year interim results of SPACE-2. International Journal of Stroke. https://dx.doi.org/10.1177/1747493019833017
Mayer, I.A., Prat, A., Egle, D., Blau, S., Alejandro Perez Fidalgo, J., Gnant, M.,... Arteaga, C.L. (2019). A phase II randomized study of neoadjuvant letrozole plus alpelisib for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (NeO-ORB). Clinical Cancer Research, 25(10), 2975-2987. https://dx.doi.org/10.1158/1078-0432.CCR-18-3160
Wunderle, M., Pretscher, J., Brucker, S.Y., Volz, B., Hartmann, A., Fiessler, C.,... Rauh, C. (2019). Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment, 174(2), 453-461. https://dx.doi.org/10.1007/s10549-018-05115-6
Kuta, P., Melling, N., Zimmermann, R., Achenbach, S., Eckstein, R., & Strobel, J. (2019). Clotting factor activity in fresh frozen plasma after thawing with a new radio wave thawing device. Transfusion, 59(5), 1857-1861. https://dx.doi.org/10.1111/trf.15246
Konrad, E., Nardini, N., Caliebe, A., Nagel, I., Young, D., Horvath, G.,... Zweier, C. (2019). CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum. Genetics in Medicine. https://dx.doi.org/10.1038/s41436-019-0585-z
Scheer, M., Vokuhl, C., Blank, B., Hallmen, E., Von Kalle, T., Muenter, M.,... Koscielniak, E. (2019). Desmoplastic small round cell tumors: Multimodality treatment and new risk factors. Cancer Medicine, 8(2), 527-542. https://dx.doi.org/10.1002/cam4.1940
Laakmann, E., Witzel, I., Fasching, P., Rezai, M., Schem, C., Solbach, C.,... Loibl, S. (2019). Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto. Breast Cancer Research, 21(1). https://dx.doi.org/10.1186/s13058-019-1144-x
Tesch, H., Stoetzer, O., Decker, T., Kurbacher, C.M., Marme, F., Schneeweiss, A.,... Taran, F.-A. (2019). Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial. International Journal of Cancer, 144(4), 877-885. https://dx.doi.org/10.1002/ijc.31738
Fuhrer, H., Schoenenberger, S., Niesen, W.-D., Seide, S., Meyne, J., Gerner, S.,... Neugebauer, H. (2019). Endovascular stroke treatment’s impact on malignant type of edema (ESTIMATE). Journal of Neurology, 266(1), 223-231. https://dx.doi.org/10.1007/s00415-018-9127-x
Oosterhaven, J.A.F., Uter, W., Aberer, W., Armario-Hita, J.C., Ballmer-Weber, B.K., Bauer, A.,... Grabbe, J. (2019). European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis. Contact Dermatitis, 80(5), 263-272. https://dx.doi.org/10.1111/cod.13192
Janning, M., Müller, V., Vettorazzi, E., Cubas-Cordova, M., Gensch, V., Ben-Batalla, I.,... Loges, S. (2019). Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial. International Journal of Cancer. https://dx.doi.org/10.1002/ijc.32163
Gómez Ruiz, M., Alfieri, S., Becker, T., Bergmann, M., Boggi, U., Collins, J.,... Vaz, C. (2019). Expert consensus on a train-the-trainer curriculum for robotic colorectal surgery. Colorectal Disease. https://dx.doi.org/10.1111/codi.14637
Reinartz, G., Pyra, R.P., Lenz, G., Liersch, R., Stueben, G., Micke, O.,... Eich, H.T. (2019). Favorable radiation field decrease in gastric marginal zone lymphoma Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL). Strahlentherapie und Onkologie, 195(6), 544-557. https://dx.doi.org/10.1007/s00066-019-01446-5
Mrowietz, U., Ertner, K., Sticherling, M., Grosse, V., Popp, G., Roemmler-Zehrer, J.,... Gomez, N.N. (2019). First real-world insights on benefit of apremilast treatment in patients with moderate to severe psoriasis after switching from fumaric acid esters from the APART Study - an interim analysis. In JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (pp. 123-123). HOBOKEN: WILEY.
Piroth, M.D., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R.,... Sauer, R. (2019). Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and prevention. Strahlentherapie und Onkologie, 195(1), 1-12. https://dx.doi.org/10.1007/s00066-018-1378-z
Wallwiener, M., Nabieva, N., Feisst, M., Fehm, T., De Waal, J., Rezai, M.,... Fasching, P. (2019). Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study. BMC Cancer, 19. https://dx.doi.org/10.1186/s12885-019-5806-y
Lehnert, H., & Sieber, C. (2019). Metabolic disorders. Internist, 60(2), 113-114. https://dx.doi.org/10.1007/s00108-019-0554-2

Last updated on 2016-11-05 at 13:31